- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/417 - Imidazole-alkylamines, e.g. histamine, phentolamine
Patent holdings for IPC class A61K 31/417
Total number of patents in this class: 501
10-year publication summary
|
32
|
27
|
36
|
26
|
32
|
30
|
48
|
42
|
25
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SpringWorks Therapeutics, Inc. | 153 |
28 |
| Opus Genetics, Inc. | 45 |
26 |
| Allergan, Inc. | 2260 |
14 |
| Teikoku Pharma USA, Inc. | 87 |
10 |
| Ocuphire Pharma, Inc. | 22 |
8 |
| Centre National de La Recherche Scientifique | 10820 |
7 |
| Jiangsu Yahong Meditech Co., Ltd. | 68 |
7 |
| Belhaven Biopharma, Inc. | 17 |
6 |
| Novartis AG | 10462 |
5 |
| The Regents of the University of California | 20427 |
5 |
| Lexicon Pharmaceuticals, Inc. | 198 |
5 |
| Universite de Montpellier | 1023 |
5 |
| VALO Health, Inc. | 182 |
5 |
| Asieris Pharmaceuticals (Shanghai) Co., Ltd. | 41 |
5 |
| Bristol-myers Squibb Company | 4792 |
4 |
| Bayer HealthCare LLC | 1323 |
4 |
| The Johns Hopkins University | 5782 |
4 |
| Ltd "valenta-intellekt" | 155 |
4 |
| Tohoku University | 2885 |
4 |
| Vella Bioscience, Inc. | 26 |
4 |
| Other owners | 341 |